Back
Verisk Analytics Vs. Corcept Therapeutics Industry Stock Comparison
Sell
42
VRSK
Verisk Analytics
Last Price:
$280.55
Seasonality Move:
5%
Buy
52
CORT
Corcept Therapeutics
Last Price:
$75.37
Seasonality Move:
6.42%
Sell
42
Verisk Analytics (VRSK)
is a Sell
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $278.09. The Score for VRSK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
VRSK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $74.65. The Score for CORT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $278.09Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $74.65The current trend is moderately bullish and CORT is experiencing slight buying pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 37.28 | Sell |
Chaikin Money Flow: | -959805 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (286.21 - 298.87) | Sell |
Bollinger Bands (100): | (278.98 - 294.7) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.64 | Buy |
Relative Strength Index (14 RSI): | 54.3 | Buy |
Chaikin Money Flow: | 841196 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.33 - 78.25) | Buy |
Bollinger Bands (100): | (50.74 - 69.42) | Buy |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 294.45 | Sell |
20-day SMA: | 291 | Sell |
50-day SMA: | 291.57 | Sell |
200-day SMA: | 278.62 | Sell |
8-day EMA: | 291.07 | Sell |
20-day EMA: | 291.99 | Sell |
50-day EMA: | 290.24 | Sell |
200-day EMA: | 276.75 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.72 | Sell |
20-day SMA: | 65.73 | Buy |
50-day SMA: | 64.92 | Buy |
200-day SMA: | 49.1 | Buy |
8-day EMA: | 74.01 | Buy |
20-day EMA: | 53.91 | Buy |
50-day EMA: | 29.29 | Buy |
200-day EMA: | 8.68 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.87 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Verisk Analytics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |